Surgical treatment of hepatoblastoma

Pediatric Blood and Cancer

Volumn 59, Issue 5, 2012, Pages 800-808

  Meyers, Rebecka L ^a   Czauderna, Piotr ^b   Otte, Jean Bernard ^c  

^a PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Chemoembolization; Hepatoblastoma; Liver transplant; Pediatric liver tumor; PLUTO; PRETEXT; Surgical complications; Surgical treatment

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CONTRAST MEDIUM; DOXORUBICIN; IODINATED POPPYSEED OIL; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ARTIFICIAL EMBOLISM; BILE LEAKAGE; BLEEDING; BLOOD VESSEL INJURY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER PATIENT; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; HEART ARREST; HEPATOBLASTOMA; HUMAN; LIVER BIOPSY; LIVER FAILURE; LIVER LOBECTOMY; LIVER METASTASIS; LIVER RESECTION; LIVER TRANSPLANTATION; LUNG METASTASIS; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIATRIC SURGERY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SURGICAL ANATOMY; SURGICAL INFECTION; TREATMENT INDICATION; TUMOR BIOPSY;

DIGESTIVE SYSTEM SURGICAL PROCEDURES; HEART ARREST; HEPATOBLASTOMA; HUMANS; LIVER; LIVER FAILURE; LIVER NEOPLASMS; POSTOPERATIVE HEMORRHAGE; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR DISEASES;

EID: 84866175355     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24220     Document Type: Review

References (61)

1. Howat JM. Major hepatic resections in infancy and childhood. Gut 1971; 12: 212-217.
2. Price JB, Schullinger JN, Santali TV. Major hepatic resections for neoplasia in children. Arch Surg 1982; 117: 1139-1141.
3. Ortega JA, Kralio MD, Haas JE, et al. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin. A report from the Children's Cancer Study Group. J Clin Oncol 1991; 9: 2167-2176.
4. Perilongo G, Maibach R, Shafford E, et al. Cisplatin versus cisplatin plus doxorubicin for standard risk hepatoblastoma. N Engl J Med 2009; 361: 1662-1670.
5. Zsiros J, Maibach R, Shafford E, et al. Successful treatment of childhood high-risk hepatoblatoma with dose-intensive multiagent chemotherapy and surgery: Final results of the SIOPEL-3HR study. J Clin Oncol 2010; 28: 2584-2590.
6. Aronson DC, Schnater JM, Staalman CR, et al. Predictive value of the Pretreatment extent of disease system in hepatoblastoma: Results from the international society of pediatric oncology liver tumor study group SIOPEL-1 study. J Clin Oncol 2005; 23: 1245-1252.
7. Roebuck DJ, Aronson D, Clapuyt P, et al. 2005 PRETEXT: A revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol 2007; 37: 123-132; 1096-1100.
8. Meyers RL, Rowland JH, Krailo M, et al. Pretreatment prognostic factors in hepatoblastoma: A report of the Children's Oncology Group. Pediatr Blood Cancer 2009; 53: 1016-1022.
9. Meyers RL, Tiao GM, Dunn SP, et al. The role of liver transplantation in the management of unresectable hepatoblastoma in children. Front Biosci 2012; E4: 1293-1302. www.frontiersinbioscience.com.
10. Lautz TB, Ben-Ami T, Tantemsapya N, et al. Successful nontransplant resection of POST-TEXT III and IV hepatoblastoma. Cancer 2011; 117: 1976-1983.
11. Guerin F, Gauthier F, Martelli H, et al. Outcome of central hepatectomy for hepatoblastoma. J Pediatr Surg 2010; 45: 555-563.
12. Malogolowkin MH, Katzenstein HM, Meyers RL, et al. Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: A report from the Children's Oncology Group. J Clin Oncol 2011; 29: 3301-3306.
13. Meyers RL, Katzenstein HM, Krailo M, et al. Surgical resection of pulmonary metastatic lesions in hepatoblastoma. J Pediatr Surg 2007; 42: 2050-2056.
14. Aronson DC. Liver tumours and the SIOPEL story. SIOP Education Book. Berlin, Germany: International Society of Pediatric Oncology; 2008. pp 68-75.
15. Czauderna P, Otte JB, Aronson DC, et al. Guidelines for surgical treatment of hepatoblastoma in the modern era: Recommendations from the childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur J Cancer 2005; 41: 1031-1036.
16. Otte JB, deVille de Goyet J, Reding R. Liver transplantation for hepatoblastoma: Indications and contraindications in the modern era. Pediatr Transpl 2005; 9: 557-656.
17. Lopez-Terrada D, Gunarathe PH, Adesina AM, et al. Hepatoblastoma histologic heterogeneity may correlate with molecular heterogeneity. Hum Pathol 2009; 40: 783-794.
18. Trobaugh-Lotrario AD, Tomlinson GE, Finegold MJ, et al. Small cell undifferentiated variant of hepatoblastoma: Adverse clinical and molecular features similar to rhabdoid tumors. Pediatr Blood Cancer 2009; 52: 328-334.
19. Lovorn HN, Hilmes M, Ayres D, et al. Defining hepatoblastoma responsiveness to neoadjuvant therapy as measured by tumor volume and serum alpha-fetoprotein kinetics. J Pediatr Surg 2010; 41: 182-186.
20. Hery G, Franchi-Abella S, Habes D, et al. First line liver transplantation in unresectable hepatoblastoma after chemotherapy. Pediatr Blood Cancer 2011; 57: 1270-1275.
21. Czauderna P, VonSchweinitz D. Surgical treatment. In: Zimmermann A, Perilongo G, editors. Pediatric liver tumors. Berlin, Heidelberg: Springer Verlag; 2011. pp 113-131.
22. Clavian PA, Selzner M, Rudiger HA. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003; 238: 843-852.
23. Fuchs J, Rydzynski J, vonSchweinitz D. et al. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: A report from the German Cooperative Pediatric Liver Tumor Study HB94. Cancer 2002; 95: 172-182.
24. Grotegut S, Kappler R, Tarimoradi S, et al. Hepatocyte growth factor protects hepatoblastoma cells from chemotherapy-induced apoptosis by AKT activation. Int J Oncol 2010; 36: 1261-1267.
25. Madanur MA, Battula N, Davenport M, et al. Staged resection for a ruptured hepatoblstoma: A 6 year follow-up. Pediatr Surg Int 2007; 23: 609-611.
26. Katz SC, Shia J, Liau KH, et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 2009; 249: 617-623.
27. Superina R, Bilik R. Results of liver transplant in children with unresectable liver tumors. J Pediatr Surg 1996; 31: 835-839.
28. Reyes JD, Carr B, Dvorchik I, et al. Liver transplant and chemotherapy for hepatoblastoma and hepatocellular carcinoma in childhood and adolescence. J Pediatr 2000; 136: 795-804.
29. Al-Qabandi W, Jenkinson HC, Buckels JA, et al. Orthotopic liver transplantation for unresectable hepatoblastoma: A single center's experience. J Pediatr Surg 1999; 34: 1261-1264.
30. Meyers RL, Otte JB. Liver transplant for unresectable liver tumors in children. In: Zimmermann A, Perilongo G, editors. Pediatric liver tumors. Berlin, Heidelberg: Springer Verlag; 2011. pp 133-153.
31. Hishiki T, Matsunaga T, Sasaki F, et al. Outcome of hepatoblastoma treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: Report from the JPLT. Pediatr Surg Int 2011; 27: 1-8.
32. Warman SW, Fuchs J. Drug resistance in hepatoblastoma. Curr Pharm Biotechnol 2007; 8: 93-97.
33. Dall'Igna P, Cecchetto G, Toffolutti T, et al. Multifocal hepatoblastoma: Is there a place for partial hepatectomy? Med Pediatr Oncol 2003; 40: 113-117.
34. Stringer MD. The role of liver transplantation in the management of paediatric liver tumours. Ann R Coll Surg Engl 2007; 89: 12-21.
35. Otte JB, Pritchard J, Aronson DC, et al. Liver transplantation for hepatoblastoma: Results from the International Society of Pediatric Oncology (SIOP) Study SIOPEL-1 and Review of the World Experience. Pediatr Blood Cancer 2004; 42: 74-83.
36. Pimpalwar AP, Sharif K, Ramani P, et al. Strategy for hepatoblastoma management: Transplant versus nontransplant surgery. J Pediatr Surg 2002; 37: 240-245.
37. Avila LF, Encinas JL, Leal N, et al. Liver transplantation for malignant tumors in children. Cir Pediatr 2007; 20: 189-193.
38. Cassas-Medley AT, Malatack J, Consoliai D, et al. successful liver transplant for unresectable hepatoblastoma. J Pediatr Surg 2007; 42: 184-187.
39. Browne M, Sher D, Abramson IL, et al. Survival after liver transplantation for hepatoblastoma: A two center experience. J Pediatr Surg 2008; 43: 1973-1981.
40. Otte JB, Meyers RL. PLUTO: First report. Pediatr Transpl 2010; 14: 830-835.
41. Czauderna P, Zbrzeniak G, Narozanski W, et al. Preliminary experience with arterial chemoembolization for hepatoblatoma and hepatocellular carcinoma in children. Pediatr Blood Cancer 2006; 46: 825-828.
42. Li JP, Chu JP, Yand JY, et al. Preoperative transcatheter selective arterial chemoembolization in treatment of unresectable hepatoblastoma in infants and children. Cardiovasc Intervent Radiol 2008; 31: 1117-1123.
43. Farges O, Belgheti J, Kianmanesen R, et al. Portal vein embolization before hepatectomy: Prospective clinical trial. Ann surg 2003; 237: 208-217.
44. Ghandour K, Masarweh M, Ali H, et al. Portal vein branch ligation: An adjunct to trisegmentectomy PRETEXT III hepatoblastoma. SIOP Abstract Book, 2008, pp. 221, 40th Congress of the International Society of Pediatric Oncology, Berlin, Germany, October 2008.
45. Matsunaga T, Sasaki F, Ohira M, et al. Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma. Pediatr Surg Int 2003; 19: 142-146.
46. Meyers RL. Tumors of the liver in children. Surg Oncol 2007; 16: 195-203.
47. Wong KKY, Lan LCL, Lin SCL, et al. The use of Positron Emission Tomography in detecting hepatoblastoma recurrence-A cautionary tale. J Pediatr Surg 2004; 39: 1779-1881.
48. Smyrniotis V, Farantos C, Kostopanagiotou G, et al. Vascular control during hepatectomy: Review of methods and results. World J Surg 2005; 29: 1384-1396.
49. Vigano L, Ferrero A, Sgotto E, et al. Bile leak after hepatectomy: Predictive factors or spontaneous healing. Am J Surg 2008; 196: 195-200.
50. Perilongo G, Shafford E, Maibach R, et al. Risk adapted treatment for childhood hepatoblastoma: Final report of the second study of the International Society of Pediatric Oncology, SIOPEL 2. Eur J Cancer 2004; 40: 411-421.
51. Geller JI, Nathan JD, Wagner LM, et al. Chemotherapy and liver transplant for unresectable hepatoblastoma: The Cincinnati Children's Hospital Medical Center Experience. Abstract, SIOP Boston 2010.
52. Molmenti EP, Wilkinson R, Molmenti H, et al. Treatment of unresectable hepatoblastoma with liver transplantation in the pediatric population. Am J Transplant 2002; 2: 535-538.
53. Srinivasan P, McCall J, Pritchard J, et al. Orthotopic liver transplantation for unresectable hepatoblastoma. Transplantation 2002; 74: 652-655.
54. Cillo U, Ciarleglio FA, Bassanello M, et al. Liver transplant for the management of hepatoblastoma. Transplant Proc 2003; 35: 2983-2985.
55. Mejia A, Langnas AN, Shaw BW, et al. Living and deceased liver transplant for unresectable hepatoblastoma at a single center. Clin Transplant 2005; 19: 721-725.
56. Kasahara M, Ueda M, Haga H, et al. Living-donor liver transplantation for hepatoblastoma. Am J Transplant 2005; 5: 2229-2235.
57. Chen LE, Shepherd RW, Nadler ML, et al. Liver transplantation and chemotherapy in children with unresectable primary hepatic malignancy. J Pediatr Gastroenterol Nutr 2006; 43: 487-493.
58. Beaunoyer M, Vanetta JM, Ogihara M, et al. Outcomes of transplantation in children with primary hepatic malignancy. Pediatr Transplant 2007; 11: 655-660.
59. Faraj W, Dar F, Marangoni G, et al. Liver transplantation for hepatoblastoma. Liver Transplant 2008; 14: 1614-1619.
60. Kalicinski P, Ismail H, Broniszczak D, et al. Non-resectable hepatic tumors in children-Role of liver transplantation. Ann Transplant 2008; 13: 37-41.
61. Hery G, Franchi-Abella S, Habes D, et al. Initial liver transplantation for unresectable hepatoblastoma after chemotherapy. Pediatr Blood Cancer 2011; 57: 1270-1275.